Charles River Laboratories
333 hedge funds and large institutions have $5.03B invested in Charles River Laboratories in 2018 Q1 according to their latest regulatory filings, with 44 funds opening new positions, 123 increasing their positions, 116 reducing their positions, and 44 closing their positions.
6% more repeat investments, than reductions
Existing positions increased: 123 | Existing positions reduced: 116
4% more call options, than puts
Call options by funds: $4.43M | Put options by funds: $4.25M
0% more first-time investments, than exits
New positions opened: 44 | Existing positions closed: 44
0.28% less ownership
Funds ownership: 99.74% → 99.46% (-0.28%)
3% less capital invested
Capital invested by funds: $5.16B → $5.03B (-$133M)
2% less funds holding
Funds holding: 339 → 333 (-6)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wells Fargo
San Francisco,
California
|
+$109M |
| 2 |
Alyeska Investment Group
Chicago,
Illinois
|
+$66.6M |
| 3 |
Millennium Management
New York
|
+$37.8M |
| 4 |
William Blair Investment Management
Chicago,
Illinois
|
+$32.5M |
| 5 |
DekaBank Deutsche Girozentrale
Frankfurt,
Germany
|
+$25M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
-$39.9M |
| 2 |
Mackenzie Financial
Toronto Ontario,
Ontario, Canada
|
-$37.9M |
| 3 |
D.E. Shaw & Co
New York
|
-$31M |
| 4 |
CTA
Carillon Tower Advisers
St. Petersburg,
Florida
|
-$27.4M |
| 5 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$24.9M |
CRL Hedge Fund Activity: Q1 2018 in Review
333 of the 4,373 institutional investors tracked by Wall St. Rank reported a position in Charles River Laboratories (CRL) for Q1 2018, worth a combined $5.03B — down 2.6% from $5.16B a quarter earlier.
Fund positioning in CRL was balanced in Q1 2018: 44 funds opened new positions, 44 closed out, 123 added to existing stakes and 116 trimmed.
The largest buyer was Wells Fargo, adding an estimated $109M. The largest seller was Eagle Asset Management, exiting entirely with an estimated $39.9M sold.
- 333 institutional investors held Charles River Laboratories (CRL) as of Q1 2018, down from 339 in Q4 2017.
- Funds reported $5.03B of Charles River Laboratories stock for Q1 2018, down 2.6% quarter-over-quarter.
- 44 funds opened new Charles River Laboratories positions in Q1 2018 and 44 closed out, a net change of 0 holders.
- The largest Charles River Laboratories buyer in Q1 2018 was Wells Fargo, an estimated $109M added.
- The largest Charles River Laboratories seller in Q1 2018 was Eagle Asset Management, an estimated $39.9M sold.
Based on aggregated 13F filings for Q1 2018.